Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascepa for Vascular Inflammation in Community-Acquired Pneumonia
NCT06710080Phase 3Recruiting
- Sponsor
- University of Ottawa Heart Institute
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in community acquired pneumonia (CAP), atherosclerosis, sponsored by University of Ottawa Heart Institute. Started Apr 2026; status: recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
community acquired pneumonia (CAP)atherosclerosis
Beyond the preview
Go deeper on NCT06710080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710080.